Supplementary Data 1 from Pilot Study of ONCOS-102 and Pembrolizumab: Remodeling of the Tumor Microenvironment and Clinical Outcomes in Anti–PD-1–Resistant Advanced Melanoma

Supplementary Data 1 from Pilot Study of ONCOS-102 and Pembrolizumab: Remodeling of the Tumor Microenvironment and Clinical Outcomes in Anti–PD-1–Resistant Advanced Melanoma

<p>Immunologic pathway genes</p>

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awdur: Alexander N. Shoushtari (15023909) (author)
Awduron Eraill: Anthony J. Olszanski (15031292) (author), Marta Nyakas (15051200) (author), Thomas J. Hornyak (15051203) (author), Jedd D. Wolchok (15032924) (author), Victor Levitsky (15051206) (author), Lukasz Kuryk (15051209) (author), Thomas B. Hansen (15051212) (author), Magnus Jäderberg (15051215) (author)
Cyhoeddwyd: 2025
Pynciau:
Cancer
Tumor Biology
Clinical Research and Trials
Clinical-Stage Research
Skin Cancers
Melanoma
Tumor Microenvironment
Immune cells and the microenvironment
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg